Table 1.
Characteristics of participants by mental health status at the end of follow-up
| No mental health diagnosis | Mental health diagnosis | Total | |
|---|---|---|---|
| N = 33,635 (61.9) | N = 20,743 (38.1) | N = 54,378 (100.0) | |
| Age, years | |||
| 15–19 | 828 (2.5) | 385 (1.9) | 1213 (2.2) |
| 20–24 | 698 (2.1) | 329 (1.6) | 1027 (1.9) |
| 25–34 | 8524 (25.3) | 5498 (26.5) | 14,022 (25.8) |
| 35–44 | 12,474 (37.1) | 8259 (39.8) | 20,733 (38.1) |
| 45–54 | 8117 (24.1) | 4898 (23.6) | 13,015 (23.9) |
| 55–64 | 2720 (8.1) | 1267 (6.1) | 3987 (7.3) |
| 65+ | 274 (0.8) | 107 (0.5) | 381 (0.7) |
| Mean (SD) | 40.2 (10.1) | 39.8 (9.4) | 40.1 (9.9) |
| Sex | |||
| Male | 15,219 (45.2) | 7131 (34.4) | 22,350 (41.1) |
| Female | 18,416 (54.8) | 13,612 (65.6) | 32,028 (58.9) |
| ART regimen at baseline | |||
| NNRTI-based | 29,650 (88.2) | 18,118 (87.3) | 47,768 (87.8) |
| II-based | 200 (0.6) | 131 (0.6) | 331 (0.6) |
| PI-based | 3785 (11.3) | 2494 (12.0) | 6279 (11.5) |
| Follow-up time, years | |||
| Median (IQR) | 3.0 (1.5–5.4) | 4.9 (2.8–7.6) | 3.5 (1.9–6.4) |
| Mental health diagnoses | |||
| Organic mental disorder | 0 (0.0) | 488 (2.4) | 488 (0.9) |
| Substance use disorder | 0 (0.0) | 429 (2.1) | 429 (0.8) |
| Serious mental disorder | 0 (0.0) | 1235 (6.0) | 1235 (2.3) |
| Depression | 0 (0.0) | 11,000 (53.0) | 11,000 (20.2) |
| Anxiety | 0 (0.0) | 14,248 (68.7) | 14,248 (26.2) |
| Other mental disorders | 0 (0.0) | 3446 (16.6) | 3446 (6.3) |
Data are number of participants and percentages if not stated otherwise
SD standard deviation, IQR interquartile range, ART antiretroviral therapy, NNRTI non-nucleoside reverse transcriptase inhibitors, II integrase inhibitor, PI protease inhibitor